PGY-2 Medication-Use Safety & Policy Residency

Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Additional Program Description

This specialty residency is designed to develop practitioners who possess an expert level of competency in drug information practice, formulary management, medication safety, and policies/procedures. The program allows sufficient flexibility to adapt to the individual needs of the resident, while ensuring that all ASHP standards for drug information specialized residency training are met.

Upon completion of this program, the resident will be prepared to enter a variety of positions related to MSUP practice. A resident who successfully completes an accredited PGY2 MSUP Residency should possess the skills needed to excel in the following positions: clinical specialist in Drug Information, Drug Information faculty member, coordinator/manager of Drug Information Services, medical writer/editor, formulary manager/specialist, or medication safety pharmacist. Additionally, upon completion of the PGY2 program, the resident should possess competencies that enable attainment of board certification (ie, BCPS).

Program Design

Required Learning Experiences

  • Orientation - 1 month
  • Drug Information - 11 months (longitudinal)
  • Drug Information Precepting - 2 months
  • Medication Safety, Use & Policy I - 2 to 4 weeks (additional and more longitudinal experiences depending on availability/need/interest)
  • Medication Safety, Use & Policy II - 2 to 4 weeks (additional and more longitudinal experiences depending on availability/need/interest)
  • Formulary Management (P&T) - 4 to 6 months

Elective Learning Experiences

  • Informatics - 4 to 6 weeks (or longitudinal)
  • Drug Information - Teaching (Academia) - 1 semester (fall)
  • Clinic experience - Half day per week (longitudinal: 4 to 6 months)

Clinical Staffing Service

Residents will gain clinical experience providing service throughout the year as a clinical pharmacist. PGY2 residents staff every 3rd or 4th weekend in one of the inpatient pharmacies (Ashley River Tower, Children’s Hospital, and University Hospital). Residents will be scheduled in a variety of central and decentralized roles so they gain experience providing a wide range of services. Activities include, but are not limited to, order verification, sterile product verification, completing pharmacokinetic monitoring, providing therapeutic consults, attending emergency codes, and delivering patient education.

Research Project

Each resident will complete a major service or research project during the residency year. Project ideas will be generated by care team members of MUSC Health to address clinical and operational needs for Pharmacy Services and patients at MUSC Health. The resident will present the results of their project at a local, state, regional, or national meeting, and they must write a manuscript suitable for publication describing the results of their project.

MUE

PGY2 residents will participate in small-group medication use evaluations to evaluate and implement measures to improve the quality of the medication-use process.

Seminar

Each resident will present one ACPE-accredited seminar during the residency program. The goal of the seminar is to expand the resident’s communication skills, presentation techniques, and knowledge in a topic of their choosing.

Core Preceptors

Jimmy New, PharmD, BCPS
Clinical Specialist, Medication Safety, Use & Policy
new@musc.edu

Sandy Still, PharmD, BCPS
Manager, Medication Safety, Use & Policy
stillal@musc.edu

Hannah Vining, PharmD, MBA, BCPS
Clinical Specialist, Medication Safety, Use & Policy
viningh@musc.edu

Chris Wisniewski, PharmD, MSCR, BCPS
Clinical Specialist, Medication Safety, Use & Policy Professor, MUSC College of Pharmacy
wisniews@musc.edu

Kathryn Noyes, PharmD, BCPS
Clinical Specialist, Medication Safety, Use & Policy
noyes@musc.edu

Dixie Runey, PharmD, BCPS
Clinical Specialist, Medication Safety, Use & Policy
stephed@musc.edu

Requirements for Program Completion

The resident is expected to successfully complete and achieve all of the required outcomes according to ASHP Educational Outcomes, Goals and Objectives for the PGY2 MUSP Residency and all of the selected elective outcomes. The required outcomes for this program listed below should all be achieved for successful completion of the program. Custom outcomes will be available for operational staffing learning experiences.

The resident is expected to demonstrate proficiency in 95% or above of all activities linked to these specific outcomes via the various goals and objectives assigned from the learning experiences to successfully complete the program (see MUSC Residency Manual). The resident will observe, learn, act, and then master a particular activity, which will deem the resident as achieving that goal. This again will be highly individualized and not applied to every resident exactly the same.

Each learning experience will be evaluated using PharmAcademic. The resident will be assigned formative evaluations through the program as determined through the customized plan process. The formative evaluations may be evaluated through PharmAcademic or as other written/verbal communication (eg, editorial feedback on a writing assignment). All assignments/projects with associated feedback will be maintained in the resident’s online folder.

See Appendix A in our Residency Manual for standard requirements for all residency programs.